Inactivated West Nile Virus (WNV) vaccine, Duvaxyn WNV, protects against a highly neuroinvasive lineage 2 WNV strain in mice

Vaccine

Volumn 31, Issue 37, 2013, Pages 3856-3862

  Venter, Marietjie ^a,b   van Vuren, Petrus Janse ^b   Mentoor, Juliet ^a   Paweska, Janusz ^b,c   Williams, June ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Cross protection; Duvaxyn WNV vaccine; Horses; Inactivated vaccine; Lineage 1; Lineage 2; Neutralising antibodies; West Nile Virus

Indexed keywords

INACTIVATED VIRUS VACCINE; NEUTRALIZING ANTIBODY; VIRUS RNA; WEST NILE VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; AUTOPSY; BRAIN TISSUE; CONTROLLED STUDY; ENCEPHALITIS; HISTOPATHOLOGY; IMMUNITY; IMMUNOHISTOCHEMISTRY; LINEAGE 2 WEST NILE VIRUS; MALE; MORTALITY; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SOUTH AFRICA; VACCINATION; VIRUS CULTURE; VIRUS DETECTION; VIRUS REPLICATION; VIRUS STRAIN; WEST NILE FLAVIVIRUS;

CROSS PROTECTION; DUVAXYN WNV VACCINE; HORSES; INACTIVATED VACCINE; LINEAGE 1; LINEAGE 2; NEUTRALISING ANTIBODIES; WEST NILE VIRUS;

ANIMALS; ANTIBODIES, NEUTRALIZING; BRAIN; CROSS REACTIONS; HORSES; MALE; MICE; MICE, INBRED BALB C; RNA, VIRAL; VACCINES, INACTIVATED; WEST NILE FEVER; WEST NILE VIRUS; WEST NILE VIRUS VACCINES;

EID: 84881551744     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.059     Document Type: Article

References (40)

1. Ward M.P., Schuermann J.A., Highfield L.D., Murray K.O. Characteristics of an outbreak of West Nile Virus encephalomyelitis in a previously uninfected population of horses. Vet Microbiol 2006, 118(December (3-4)):255-259.
2. Ward M.P., Levy M., Thacker H.L., Ash M., Norman S.K., Moore G.E., et al. Investigation of an outbreak of encephalomyelitis caused by West Nile Virus in 136 horses. J Am Vet Med Assoc 2004, 225(July (1)):84-89.
3. Schuler L.A., Khaitsa M.L., Dyer N.W., Stoltenow C.L. Evaluation of an outbreak of West Nile Virus infection in horses: 569 cases (2002). J Am Vet Med Assoc 2004, 225(October (7)):1084-1089.
4. Durand J.P., Simon F., Tolou H. West Nile Virus: in France again, in humans and horses. Rev Prat 2004, 54(April (7)):703-710.
5. Dauphin G., Zientara S., Zeller H., Murgue B. West Nile: worldwide current situation in animals and humans. Comp Immunol Microbiol Infect Dis 2004, 27(September (5)):343-355.
6. Beasley D.W. Recent advances in the molecular biology of West Nile Virus. Curr Mol Med 2005, 5(December (8)):835-850.
7. Dauphin G., Zientara S. West Nile Virus: recent trends in diagnosis and vaccine development. Vaccine 2007, 25(30):5563-5576.
8. Burt F.J., Grobbelaar A.A., Leman P.A., Anthony F.S., Gibson G.V., Swanepoel R. Phylogenetic relationships of southern African West Nile Virus isolates. Emerg Infect Dis 2002, 8(August (8)):820-826.
9. Bakonyi T., Ivanics E., Erdelyi K., Ursu K., Ferenczi E., Weissenbock H., et al. Lineage 1 and 2 strains of encephalitic West Nile Virus, central Europe. Emerg Infect Dis 2006, 12(April (4)):618-623.
10. Kutasi O., Biksi I., Bakonyi T., Ferenczi E., Lecollinet S., Bahuon C., et al. Equine encephalomyelitis outbreak caused by a genetic lineage 2 West Nile Virus in Hungary. Am Assoc Equine Pract Proc 2009, 65:179.
11. Kutasi O., Bakonyi T., Lecollinet S., Biksi I., Ferenczi E., Bahuon C., et al. Equine encephalomyelitis outbreak caused by a genetic lineage 2 West Nile Virus in Hungary. J Vet Intern Med 2011, 25(May-June (3)):586-591.
12. Bakonyi T., Ferenczi E., Erdelyi K., Kutasi O., Csorgo T., Seidel B., et al. Explosive spread of a neuroinvasive lineage 2 West Nile Virus in Central Europe, 2008/2009. Vet Microbiol 2013, 165(July (1-2)):61-70.
13. Danis K., Baka A., Pangiotopoulos T., Economopoulou A., Saraglou G., Papa-Konidari A., et al. ECDC threat assessment: outbreak of West Nile Virus infection in Greece, July-August 2010 2010, 1-6. European Center for Disease Prevention and Control.
14. Platonov A.E., Fedorova M.V., Karan L.S., Shopenskaya T.A., Platonov O.V., Zhuravlev V.I. Epidemiology of West Nile infection in Volgograd, Russia, in relation to climate change and mosquito (Diptera: Culicidae) bionomics. Parasitol Res 2008, 103(Suppl 1):S45-S53.
15. Wodak E., Richter S., Bago Z., Revilla-Fernandez S., Weissenbock H., Nowotny N., et al. Detection and molecular analysis of West Nile Virus infections in birds of prey in the eastern part of Austria in 2008 and 2009. Vet Microbiol 2011, 149(May (3-4)):358-366.
16. Papa A., Bakonyi T., Xanthopoulou K., Vasquez A., Tenorio A., Nowotny N. Genetic characterisation of West Nile Virus lineage 2, Greece, 2010. Emerg Infect Dis 2011, 17(5):920-922.
17. Papa A., Danis K., Baka A., Bakas A., Dougas G., Lytras T., et al. Ongoing outbreak of West Nile Virus infections in humans in Greece, July-August 2010. Euro Surveill 2010, 5(34):19644.
18. Papa A., Perperidou P., Tzouli A., Castilletti C. West Nile Virus - neutralising antibodies in humans in Greece. Vector Borne Zoonotic Dis 2010, 10(7):655-658.
19. Papa A., Xanthopoulou K., Gewehr S., Mourelatos S. Research note: detection of West Nile Virus lineage 2 in mosquitoes during a human outbreak in Greece. Clin Microbiol Infect 2011, 17(Aug (8)):1176-1180.
20. Danis K., Papa A., Papanikolaou E., Dougas G., Terzaki I., Baka A., et al. Ongoing outbreak of West Nile Virus infection in humans, Greece, July to August 2011. Euro Surveill 2011, 16(34).
21. Sirbu A., Ceianu C.S., Panculescu-Gatej R.I., Vasquez A., Tenorio A., Rebreanu R., et al. Outbreak of West Nile Virus infection in humans, Romania, July to October 2010. Euro Surveill 2011, 16(2):19762-19767.
22. Savini G., Capelli G., Monaco F., Polci A., Russo F., Di Gennaro A., et al. Evidence of West Nile Virus lineage 2 circulation in Northern Italy. Vet Microbiol 2012, 158(August (3-4)):267-273.
23. Bagnarelli P., Marinelli K., Trotta D., Monachetti A., Tavio M., Del Gobbo R., et al. Human case of autochthonous West Nile Virus lineage 2 infection in Italy, September 2011. Euro Surveill 2011, 16.(43).
24. Guthrie A.J., Howell P.G., Gardner I.A., Swanepoel R.E., Nurton J.P., Harper C.K., et al. West Nile Virus infection of thoroughbred horses in South Africa (2000-2001). Equine Vet J 2003, 35(September (6)):601-605.
25. Jupp P.G. The ecology of West Nile Virus in South Africa and the occurrence of outbreaks in humans. Ann N Y Acad Sci 2001, 951(December):143-152.
26. Lanciotti R.S., Ebel G.D., Deubel V., Kerst A.J., Murri S., Meyer R., et al. Complete genome sequences and phylogenetic analysis of West Nile Virus strains isolated from the United States, Europe, and the Middle East. Virology 2002, 298(June (1)):96-105.
27. Venter M., Swanepoel R. West Nile Virus lineage 2 as a cause of zoonotic neurological disease in humans and horses in southern Africa. Vector Borne Zoonotic Dis 2010, 10(October (7)):659-664.
28. Venter M., Human S., Zaayman D., Gerdes G.H., Williams J., Steyl J., et al. Lineage 2 West Nile Virus as cause of fatal neurologic disease in horses, South Africa. Emerg Infect Dis 2009, 15(June (6)):877-884.
29. Botha E.M., Markotter W., Wolfaardt M., Paweska J.T., Swanepoel R., Palacios G., et al. Genetic determinants of virulence in pathogenic lineage 2 West Nile Virus strains. Emerg Infect Dis 2008, 14(February (2)):222-230.
30. Venter M., Myers T.G., Wilson M.A., Kindt T.J., Paweska J.T., Burt F.J., et al. Gene expression in mice infected with West Nile Virus strains of different neurovirulence. Virology 2005, 342(1):119-140.
31. Venter M., van Niekerk S., Williams J., van Eeden C., Freeman F. Fatal neurologic disease and abortion in mare infected with lineage 1 West Nile Virus, South Africa. Emerg Infect Dis 2011, 17(Aug (8)):1534-1536.
32. Minke J.M., Siger L., Karaca K., Austgen L., Gordy P., Bowen R., et al. Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile Virus protects horses against a West Nile virus-mosquito challenge. Arch Virol Suppl 2004, 18:221-230.
33. Minke J.M., Siger L., Cupillard L., Powers B., Bakonyi T., Boyum S., et al. Protection provided by a recombinant ALVAC((R))-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain. Vaccine 2011, 29(June (28)):4608-4612.
34. Chu J.H., Chiang C.C., Ng M.L. Immunization of flavivirus West Nile recombinant envelope domain III protein induced specific immune response and protection against West Nile Virus infection. J Immunol 2007, 178(March (5)):2699-2705.
35. Bonafe N., Rininger J.A., Chubet R.G., Foellmer H.G., Fader S., Anderson J.F., et al. A recombinant West Nile Virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells. Vaccine 2009, 27(January (2)):213-222.
36. Lennette E.H., Smith T.F. Laboratory diagnosis of viral infections 1999, M. Dekker.
37. Zaayman D., Human S., Venter M. A highly sensitive method for the detection and genotyping of West Nile Virus by real-time PCR. J Virol Methods 2009, 157(May (2)):155-160.
38. Haines D.M., Chelack B.J. Technical considerations for developing enzyme immunohistochemical staining procedures on formalin-fixed paraffin-embedded tissues for diagnostic pathology. J Vet Diagn Invest 1991, 3:101-112.
39. Minke J.M., Siger L., Cupillard L., Powers B., Bakonyi T., Boyum S., et al. Protection provided by a recombinant ALVAC((R))-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain. Vaccine 2013, 29(June (28)):4608-4612.
40. Sallusto F., Lanzavecchia A., Araki K., Ahmed R. From vaccines to memory and back. Immunity 2010, 33(October (4)):451-463.